Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (753)
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
522
Price
$147.14
Total Value
$76.81K
Shares Held After
3,780
% of Holdings
12.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
4,730
Price
$26.91
Total Value
$127.28K
Shares Held After
37,109
% of Holdings
11.3%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
1,389
Price
$1.55
Total Value
$2.15K
Shares Held After
75,017
% of Holdings
1.9%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
13,761
Price
$1.55
Total Value
$21.33K
Shares Held After
743,038
% of Holdings
1.9%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
1,600
Price
$2.44
Total Value
$3.90K
Shares Held After
2,835,581
% of Holdings
0.1%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
53,336
Price
$67.60
Total Value
$3.61M
Shares Held After
1,483,848
% of Holdings
3.5%
Monte Rosa Therapeutics, Inc. (GLUE)
Champoux Jennifer — Chief Operating Officer
Shares
4,351
Price
$23.38
Total Value
$101.73K
Shares Held After
62,371
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$534.27
Total Value
$64.11K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
825
Price
$533.08
Total Value
$439.79K
Shares Held After
324,563
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,295
Price
$531.97
Total Value
$1.75M
Shares Held After
325,388
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,044
Price
$531.03
Total Value
$554.39K
Shares Held After
328,683
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
577
Price
$530.12
Total Value
$305.88K
Shares Held After
329,727
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
641
Price
$529.03
Total Value
$339.11K
Shares Held After
330,304
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$527.77
Total Value
$63.33K
Shares Held After
330,945
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$525.24
Total Value
$147.07K
Shares Held After
331,065
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$524.40
Total Value
$230.73K
Shares Held After
331,345
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
203
Price
$523.20
Total Value
$106.21K
Shares Held After
331,785
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
189
Price
$521.84
Total Value
$98.63K
Shares Held After
331,988
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
48
Price
$520.92
Total Value
$25.00K
Shares Held After
332,177
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$534.09
Total Value
$21.36K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$533.22
Total Value
$85.31K
Shares Held After
40,553
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$532.06
Total Value
$425.65K
Shares Held After
40,713
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
278
Price
$530.97
Total Value
$147.61K
Shares Held After
41,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$529.66
Total Value
$63.56K
Shares Held After
41,791
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$527.55
Total Value
$21.10K
Shares Held After
41,911
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$525.42
Total Value
$42.03K
Shares Held After
41,951
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$523.97
Total Value
$62.88K
Shares Held After
42,031
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$521.82
Total Value
$41.75K
Shares Held After
42,151
% of Holdings
0.2%
INCYTE CORP (INCY)
Stein Steven H — CMO&Head of Late-Stage Dev.
Shares
28,237
Price
$113.05
Total Value
$3.19M
Shares Held After
26,083
% of Holdings
52.0%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
2,797
Price
$3.28
Total Value
$9.17K
Shares Held After
974,967
% of Holdings
0.3%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,349
Price
$26.61
Total Value
$168.95K
Shares Held After
51,384
% of Holdings
11.0%
Fulcrum Therapeutics, Inc. (FULC)
TANG KEVIN — 10% Owner
Shares
107,377
Price
$3.56
Total Value
$382.26K
Shares Held After
6,913,329
% of Holdings
1.6%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
300
Price
$87.25
Total Value
$26.18K
Shares Held After
32,718
% of Holdings
0.9%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
3,803
Price
$86.68
Total Value
$329.63K
Shares Held After
33,018
% of Holdings
10.3%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,497
Price
$85.86
Total Value
$214.39K
Shares Held After
36,821
% of Holdings
6.4%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
400
Price
$84.36
Total Value
$33.75K
Shares Held After
39,318
% of Holdings
1.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,500
Price
$0.86
Total Value
$1.29K
Shares Held After
368,385
% of Holdings
0.4%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
493
Price
$1.55
Total Value
$764.15
Shares Held After
73,628
% of Holdings
0.7%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
4,882
Price
$1.55
Total Value
$7.57K
Shares Held After
729,277
% of Holdings
0.7%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
43,878
Price
$2.43
Total Value
$106.62K
Shares Held After
2,833,981
% of Holdings
1.5%
Eton Pharmaceuticals, Inc. (ETON)
Opaleye Management Inc. — 10% Owner
Shares
13,315
Price
$37.54
Total Value
$499.89K
Shares Held After
40,000
% of Holdings
25.0%
Eton Pharmaceuticals, Inc. (ETON)
Opaleye Management Inc. — 10% Owner
Shares
15,000
Price
$37.54
Total Value
$563.15K
Shares Held After
2,665,000
% of Holdings
0.6%
PTC THERAPEUTICS, INC. (PTCT)
Gravier Pierre — CHIEF FINANCIAL OFFICER
Shares
3,494
Price
$80.35
Total Value
$280.74K
Shares Held After
83,986
% of Holdings
4.0%
Celcuity Inc. (CELC)
BAKER BROS. ADVISORS LP — Former 10% owner
Shares
2,838,632
Price
$102.50
Total Value
$290.96M
Shares Held After
4,372,852
% of Holdings
39.4%
Celcuity Inc. (CELC)
BAKER BROS. ADVISORS LP — Former 10% owner
Shares
261,368
Price
$102.50
Total Value
$26.79M
Shares Held After
442,940
% of Holdings
37.1%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
16,250
Price
$5.13
Total Value
$83.28K
Shares Held After
0
% of Holdings
100.0%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
2,000
Price
$2.65
Total Value
$5.30K
Shares Held After
387,075
% of Holdings
0.5%
Cardiff Oncology, Inc. (CRDF)
Mohindru Mani — Director
Shares
34,364
Price
$1.46
Total Value
$50.00K
Shares Held After
59,067
% of Holdings
58.2%
Cardiff Oncology, Inc. (CRDF)
PACE GARY W — Director
Shares
687,285
Price
$1.46
Total Value
$1000.00K
Shares Held After
2,043,661
% of Holdings
33.6%
Fulcrum Therapeutics, Inc. (FULC)
TANG KEVIN — 10% Owner
Shares
75,952
Price
$3.58
Total Value
$271.91K
Shares Held After
6,805,952
% of Holdings
1.1%
Showing 101–150 of 753 transactions (page 3 of 16)